Protocol and Baseline Traits of the Monitoring in Dialysis Examine

Ultrafiltration Rate and Mortality in Maintenance Hemodialysis Patients
July 2, 2021 0 Comments

Clin J Am Soc Nephrol. 2016 Apr 7; 11(4): 721–734.

,corresponding author* , ,§ , , , and **, on behalf of the MiD Investigators and Committees
Supplementary Supplies

Summary

Background

Dialysis sufferers have excessive charges of cardiovascular morbidity and mortality, however knowledge on arrhythmia burden, arrhythmia sort, arrhythmia triggers, and the id of terminal arrhythmias have traditionally been restricted by an incapability to watch coronary heart rhythm for extended intervals.

Aims

To analyze arrhythmia and its affiliation with sudden dying in dialysis-dependent ESRD, describe the potential for implantable gadgets to advance research of dialysis physiology, evaluate the moral implications of utilizing implantable gadgets in scientific research, and report on the protocol and baseline outcomes of the Monitoring in Dialysis Examine (MiD).

Design, setting, contributors, & measurements

On this multicenter, interventional-observational, potential cohort research, we positioned implantable loop recorders in sufferers present process long-term hemodialysis. The proportion of sufferers experiencing clinically vital arrhythmias was the first endpoint. For six months, we captured detailed knowledge on the first endpoint, symptomatic arrhythmias, different electrocardiographic variables, dialysis prescription, electrolytes, dialysis-related variables, and very important indicators. We collected extra electrocardiographic knowledge for as much as 1 yr.

Outcomes

Total, 66 sufferers underwent implantation in websites in the USA and India. Diabetes was current in 63.6% of sufferers, 12.1% had been age ≥70 years, 69.7% had been males, and 53.0% had been black. Main and secondary endpoint knowledge are anticipated in 2016.

Conclusions

Cardiac arrhythmia is a crucial contributor to cardiovascular morbidity and mortality in dialysis sufferers, however obtainable know-how has beforehand restricted the flexibility to estimate its true burden and triggers and to outline terminal rhythms in sudden dying. Use of implantable know-how in observational research raises advanced points however might enormously develop understanding of dialysis physiology. Using implantable loop recorders in MiD is among the many first examples of such a trial, and the outcomes are anticipated to offer novel insights into the character of arrhythmia in hemodialysis sufferers.

Key phrases: scientific trial, heart problems, hemodialysis, arrhythmias, cardiac, cohort research, dying, sudden, coronary heart conduction system, people, kidney failure, continual, renal dialysis

Introduction

Dialysis sufferers expertise excessive cardiovascular and all-cause mortality. The dying charge for all United States dialysis sufferers in 2011 was 198 per 1000 patient-years, with cardiac illness accounting for roughly 40% (1). Within the US Renal Information System database, two thirds of cardiac deaths are attributed to arrhythmia, making up 26% of mortality. Equally, within the Hemodialysis Examine and Die Deutsche Diabetes Dialyse Studie trials, 22% and 26% of deaths, respectively, had been sudden (2,3). Probably the most convincing validation of registry knowledge is supplied by the EValuation Of Cinacalcet HCl Remedy to Decrease CardioVascular Occasions research, the biggest randomized dialysis trial, which enrolled 3883 hyperparathyroid hemodialysis (HD) sufferers. Total, 25% of deaths had been adjudicated as sudden deaths (4), resolving hypothesis on the relative significance of (presumed) sudden cardiac dying (SCD) in HD sufferers ( and ) (1,4).

An external file that holds a picture, illustration, etc.
Object name is CJN.09350915f1.jpg

Causes of dying in prevalent dialysis sufferers, 2009–2011. AMI, acute myocardial infarction; CHF, congestive coronary heart failure; CVA, cerebrovascular accident. Information obtained from reference 1. The information reported right here have been equipped by the USA Renal Information System (USRDS). The interpretation and reporting of those knowledge are the duty of the creator(s) and on no account must be seen as an official coverage or interpretation of the U.S. authorities.

An external file that holds a picture, illustration, etc.
Object name is CJN.09350915f2.jpg

Adjudicated reason for dying within the EValuation Of Cinacalcet HCl Remedy to Decrease CardioVascular Occasions research inhabitants. CV, cardiovascular. Modified with permission from reference 4.

The underlying mechanisms of SCD, notably the precise sort of terminal arrhythmia (which has profound implications for prevention), stay controversial. Almost 5 years in the past, the Kidney Illness Enhancing World Outcomes Medical Replace Convention on heart problems in CKD presciently concluded, “Implantable loop recorders (ILRs) used to determine terminal arrhythmias might show helpful, however a coordinated effort could be vital given low enrollment charges anticipated in such research” (5). Moreover, the potential worth of ILRs will not be restricted to deadly arrhythmias—the detection of clinically unsuspected bradyarrhythmia and atrial fibrillation (AF) markedly widens their potential utility. On this manuscript, we evaluate knowledge on arrhythmia in HD sufferers and current the protocol and baseline knowledge from the Monitoring in Dialysis Trial (MiD), which used ILR to detect arrhythmia within the setting of HD.

SCD

Hemodialysis initiation is a time of markedly elevated threat. Wholesome Individuals (HP) is a federally mandated program established to enhance the well being of People; one main objective of HP2020 is to “cut back new instances of CKD and its issues, incapacity, dying, and financial prices” (1). Commensurate with the singularly excessive mortality charge in incident dialysis sufferers, the HP2020 CKD-14.2 objective is to cut back the dying charge throughout the first 3 months of dialysis initiation to 319.9 deaths per 1,000 patient-years (from the 2011 charge of 335.4 per 1000 patient-years). reveals the early hazard of SCD (and different cause-specific mortality) at dialysis initiation (6).

An external file that holds a picture, illustration, etc.
Object name is CJN.09350915f3.jpg

Trigger-specific mortality in 2011 incident dialysis sufferers following a primary dialysis session in a free-standing facility in keeping with the dying notification type. Modified from reference 6.

One main data hole in understanding of SCD in dialysis sufferers is ambiguity concerning the “terminal occasion,” notably in distinguishing between sudden dying as a consequence of arrhythmia and sudden dying not preventable with cardiac gadgets. Kidney Illness Enhancing World Outcomes (5) recognized the paucity of post-mortem knowledge in dialysis-related SCD as a serious data hole and highlighted the problematic nature of typical definitions: “sudden, surprising dying inside an hour of symptom onset, or unwitnessed, surprising dying with out apparent non-cardiac trigger in sufferers recognized to be effectively throughout the previous 24 hours.” What precisely is “surprising dying” in a inhabitants with a excessive burden of comorbid sickness who spend a disproportionate period of time in well being care amenities? Moreover, following withdrawal from dialysis, sufferers in the end die of terminal arrhythmias, however that is dying as a consequence of withdrawal. With out patient-centered context, one might simply (and wrongly) infer SCD because the “major” occasion from an ILR. Equally, such ailments as subarachnoid hemorrhage or aortic dissection might mimic SCD within the absence of rhythm tracings.

Many publications have highlighted methods for threat stratification to foretell SCD in dialysis sufferers. For instance, biomarkers indicating irritation and malnutrition (e.g., albumin) are related to SCD threat (7,8). Moreover (however maybe not surprisingly), there could also be heritability to SCD propensity in dialysis sufferers. Chan et al. lately reported that genetically associated members of the family on dialysis had a 1.7-fold improve within the odds of cardiac arrest in contrast with matched, unrelated controls (9). Within the common inhabitants, uncommon mutations in ionic channels trigger a number of distinct long-QT syndromes, that are related to a markedly increased threat of SCD (10). Nevertheless, polymorphisms in long-QT syndrome genes are comparatively frequent (roughly 1% of common inhabitants) (11). These genetic polymorphisms could also be extremely related and extra harmful within the context of typical HD given the fast declines in serum potassium, magnesium, and calcium, coupled with frequent publicity to medicine that trigger QT prolongation (corresponding to fluoroquinolones).

Typical 12-lead electrocardiography is an affordable methodology for evaluation of the QT interval and the QT interval corrected for coronary heart charge (a worth >460 msec for the latter is taken into account extended). Though measurement of QT dispersion as a predictor of threat has been studied in dialysis sufferers, its function in scientific observe remains to be unsure. Though ventricular arrhythmias (primarily untimely ventricular contractions) are frequent in dialysis sufferers (primarily based on 48-hour Holter monitoring), a potential research of 127 Italian HD sufferers adopted for 4 years confirmed they weren’t predictive of total mortality (12,13).

Few knowledge can be found on the sorts of deadly arrhythmias in dialysis sufferers. One paper detailed 84 sudden cardiac arrest occasions in dialysis sufferers with wearable cardioverter-defibrillators (14). On this chosen cohort, 78% of preliminary rhythms had been ventricular tachycardia (VT; 64.3%) or ventricular fibrillation (VF; 14.3%), and 21.4% had been asystole (i.e., not shockable). Unpublished knowledge (kindly equipped by Linda Becker) masking emergency medical providers knowledge on 47 cardiac arrests in 9 outpatient dialysis facilities in Seattle/King County between 1990 and 1996 confirmed that in 29 (62%) arrests the rhythm was VT or VF. A current Australian research utilizing ILRs, nevertheless, implicates bradycardia and asystole as the most important contributors to SCD in HD sufferers; this discovering suggests pump failure or noncardiac causes for the ultimate sequence of scientific occasions resulting in dying (15,16). An necessary caveat was the exceptionally lengthy dialysis classic of the research sufferers (imply±SD, 6±4 years); the kind of arrhythmia (and terminal occasion) is likely to be completely different in sufferers of newer versus older dialysis classic.

Position of Dialysis Baths

Low-potassium dialysate of 0 or 1 mEq/L (17) or <2 mEq/L (18) and decrease calcium dialysate (<2.5 mEq/L) (19) have been implicated as threat elements for SCD in massive database research. Equally, low serum magnesium ranges had been related to increased all-cause mortality in Japanese dialysis sufferers (20), however few knowledge exist on SCD threat and magnesium dialysate ranges.

Dialytic Cycle

Though nice enthusiasm exists amongst nephrology professionals for extra frequent upkeep HD, most sufferers dialyze thrice weekly, necessitating two gaps of 1 day and one hole of two days. This has lengthy been considered as physiologically difficult in sufferers with restricted capability to keep up homeostasis within the presence of metabolic and volume-related excursions from normality, the place background heart problems is the norm.

In a nationally consultant United States pattern between 2004 and 2007, one research in contrast charges of dying and cardiovascular admissions on the day after the 2-day interdialytic interval with charges on different days (21). As proven in , though total mortality, cardiovascular mortality, and cardiovascular admission charges had been increased on the day after the lengthy interval, relative occasion disparities had been particularly marked for congestive coronary heart failure (by an element of 1.8) and dysrhythmia (by an element of 1.9).

An external file that holds a picture, illustration, etc.
Object name is CJN.09350915f4.jpg

Affiliation of dialytic intervals cycle with mortality and cardiovascular hospitalizations. Annualized mortality (A) and cardiovascular admission charges (B) per 100 patient-years, on completely different days of the dialysis week. Error bars signify 95% confidence intervals. CHF, congestive coronary heart failure; CVD, heart problems; HD, hemodialysis (session); MI, myocardial infarction. Tailored from reference 21.

Related associations have been seen in a number of massive research (22–24). For instance, in a current research of newly incident HD sufferers in the UK between 2002 and 2006, hospital admission charges after the 2-day hole had been 1.7-fold increased, whereas all-cause mortality charges had been 1.22 instances increased. As with virtually all the literature to this point, this research was not particularly configured to check charges of SCD. Nonetheless, out-of-hospital dying charges had been 1.59 instances increased after the lengthy interval than after the shorter interval and only one.06 instances increased for in-hospital dying (23).

Pathophysiology of Arrhythmia in CKD

A number of cardiovascular threat elements, together with atherosclerotic coronary heart illness, left ventricular hypertrophy (LVH), and accelerated cardiac fibrosis, seem to contribute to arrhythmia pathogenesis in ESRD (25). Though arrhythmia and in the end sudden cardiac dying can happen in sufferers (within the common inhabitants) with apparently structurally regular hearts, most sufferers (notably these with CKD) have underlying structural coronary heart illness, and a few sort of acute occasion interacts with the underlying substrate to supply the deadly arrhythmia (26,27).

Though many triggers have been recognized, acute myocardial ischemia is felt to be the commonest initiating occasion within the common inhabitants (28). In sufferers with superior CKD (notably these present process dialysis), myocardial ischemia is more likely to be a contributor, however it’s also believable that myocardial ischemia (of the sort mediated by epicardial coronary artery illness) might play a much less predominant function and that different elements, corresponding to irritation and autonomic imbalance or elevated sympathetic exercise (together with sleep apnea), could also be necessary contributors to sudden cardiac dying (29,30). Hypertrophic myocardium is predisposed to each atrial and ventricular arrhythmia via the induction of extended motion potentials and elevated repolarization defects in areas of ischemia, with underling fibrosis serving as a positive substrate for propagation of arrhythmia. Whereas hypertension, diabetes, and different typical threat elements undoubtedly contribute, dialysis and uremia might straight contribute to LVH and fibrosis, which seems to speed up after dialysis initiation. In a potential research of 596 sufferers with ESRD who had no historical past of heart problems, for instance, serial echocardiography demonstrated that left ventricular mass index elevated considerably throughout the first 2 years of dialysis (31).

Processes distinctive to CKD and ESRD might largely account for rising left ventricular mass index. Mall et al. analyzed myocardial histology in sufferers with superior renal illness and famous that >90% of sufferers exhibited diffuse and uniform cardiac fibrosis with considerably larger ranges of myocardial collagen than noticed in hypertensive and valvular cardiomyopathies and diffuse moderately than the “patchy” fibrosis characterizing different circumstances (32). Amann et al. subsequently demonstrated that myocardial matrix enlargement was related to a discount of capillary density (33). Low capillary density might partly clarify sudden reductions in myocardial perfusion induced throughout dialysis. For instance, McIntyre et al. studied sufferers with ESRD who didn’t have vital coronary illness utilizing intradialytic place emission tomography and famous marked, regional reductions in myocardial perfusion throughout dialysis. Adjustments in perfusion had been accompanied by regional wall-motion abnormalities, suggesting that useful ischemia throughout dialysis will not be attributable to flow-limiting atherosclerosis (34).

The total pathogenesis of myocardial fibrosis and capillary rarefaction in ESRD is past the scope of this evaluate. Additional research is required to completely elucidate the pathways concerned. Nevertheless, a number of circulating elements, together with uneven dimethyl arginine (35,36), parathyroid hormone (37), aldosterone (38), fibroblast development factor-23 (39), angiotensin-2 (40), endogenous cardiac glycosides (41), vitamin D (42), and circulating angiogenesis inhibitors, have been implicated (35).

These observations counsel that along with the impact of LVH and coronary illness, transient myocardial ischemia induced by a mismatch between capillary provide and the hypertrophied myocardium could also be important to the era of arrhythmias (43). Conversely, myocardial fibrosis might gradual or disrupt regular conduction, resulting in bradycardia, asystole, and reentrant arrhythmias (43). Peridialytic modifications in BP, quantity standing, sympathetic tone, and electrolytes are more likely to additional contribute to arrhythmogenesis, however their actual contributions stay largely unstudied.

AF

Incidence and Prevalence of AF

Though asystole or ventricular arrhythmias are the almost definitely sorts of arrhythmia to end in sudden dying, atrial arrhythmias, notably AF, might end in vital morbidity in sufferers with ESRD. AF is more and more frequent in HD sufferers. In a research of 258,605 older contributors, the AF incidence in incident dialysis sufferers was 14.8/100 person-years, and adjusted possibilities of creating AF throughout the first yr of dialysis elevated from 11.3% in 1995 to 14.3% in 2007 (44). Equally, the prevalence of AF (identified from administrative claims) was 10.7% in 2006—a three-fold improve from 1992 (45). Lastly, the general AF prevalence in a meta-analysis of 25 dialysis research was 11.6% (46).

Dialysis as a Set off

Most proof that HD triggers AF is oblique. Echocardiographic intra-atrial and interatrial activation instances, for instance, correlate with ultrafiltration quantity and shorten considerably towards the tip of HD (47). Equally, there are peridialytic modifications in P-wave dispersion (commonplace electrocardiography), P-wave period, and the foundation imply sq. voltage of the ultimate 20 ms of the filtered P wave (signal-averaged electrocardiography)—parameters that measure atrial conduction delay and are related to AF (48,49). In a number of research, intradialytic modifications had been outstanding and had been attenuated on the conclusion of dialysis (50,51). In others, modifications weren’t detected or had been seen solely on the conclusion of dialysis after which shortly attenuated (52). Nevertheless, in a single research, P-wave period decreased and root imply sq. voltage of the ultimate 20 ms of the filtered P wave decreased from the start to the tip of dialysis, modifications suggesting a diminished threat of AF after HD (53). Adjustments in electrolytes had been related to P-wave parameters in a number of research (51,52), however associations with ultrafiltration seem extra sturdy (50,51). On steadiness, this literature means that fast ultrafiltration or different elements throughout HD acutely have an effect on conduction in a method that would set off AF however that results quickly attenuate after HD.

Extra lately, implanted defibrillators had been used to watch sufferers enrolled within the Implantable Cardioverter Defibrillator-2 Trial. AF was detected in 14 of 40 dialysis sufferers—11 receiving HD, 3 receiving peritoneal dialysis, and 9 with out recognized AF (54). AF frequency was three-fold increased on dialysis days (P=0.001) however didn’t differ with period of the interdialytic interval. Intradialytic AF was 13-fold extra frequent than within the 7 hours earlier than dialysis (P=0.03) and two-fold increased than within the 7 hours after dialysis (P=0.001), though outcomes had been largely pushed by two sufferers. Decrease dialysate potassium focus and better ultrafiltration volumes had been related to AF prevalence. Extra lately, a trial utilizing an ILR in 50 HD sufferers discovered that the lengthy interdialytic interval was essentially the most frequent interval of arrhythmia. AF was detected in 42% of sufferers, and new-onset AF was asymptomatic in 86% (16).

Penalties of AF

Associations with stroke are related within the ESRD and common populations (44–46,55,56). In a current research, for instance, stroke incidence was 5.2/100 patient-years in sufferers with AF in contrast with 1.9/100 patient-years in dialysis sufferers with out AF (46). AF can also be strongly related to mortality as a consequence of deadly stroke and different causes, the speed of which is roughly doubled (26.9 versus 13.4/100 patient-years) when AF is current (44–46). As well as, AF is an unbiased threat issue for mesenteric ischemia, a regularly deadly occasion (57), and amputation (58); though this has not been studied within the setting of ESRD, AF might result in tachyarrhythmia-induced cardiomyopathy when sustained (59). Frequent AF might thus be an necessary reason for an prolonged array of morbidity and mortality, together with deadly stroke, coronary heart failure, and deterioration in LV ejection fraction in HD sufferers.

Relevance of Subclinical AF

Though associations of subclinical AF with scientific outcomes haven’t been studied in ESRD, a number of research counsel that clinically silent AF is a crucial stroke threat issue within the common inhabitants. In a single randomized pacemaker trial, the pacemaker monitoring operate was used to document fast atrial occasions (charge ≥220 beats/min [BPM] lasting ≥5 minutes) presumed to signify AF (60). Total, 51.3% of sufferers had occasions at a median onset of 100 days. Atrial occasions had been independently related to stroke (hazard ratio, 2.8; P=0.001). Different research have demonstrated related associations between subclinical AF and subsequent overt AF or stroke (61–63). Extra lately, the Cryptogenic Stroke and Underlying AF (CRYSTAL AF) (64) research randomly assigned 441 stroke sufferers with out AF who had been present process 24-hour monitoring to an ILR or typical follow-up. AF lasting >30 seconds was detected in 30% of intervention versus 3% of management sufferers at 3 years.

These knowledge counsel that subclinical AF is a crucial contributor to stroke whereas illustrating the bounds of scientific remark and commonplace diagnostics for advancing scientific discovery. In CRYSTAL AF, newly developed implantable applied sciences enabled long-term, steady monitoring, thereby facilitating discovery of a excessive frequency of “silent” AF and a paradigm shift within the understanding of cryptogenic stroke. Enhancing understanding of SCD and its affiliation with dialysis is an apparent extension. Extra broadly, CRYSTAL AF highlights a brand new paradigm through which the increasing capabilities and reducing measurement of wearable or implantable applied sciences will facilitate seize of beforehand unmeasurable parameters and assortment of extra granular physiologic knowledge, thereby enhancing understanding of dialysis physiology.

LINQ and Reveal XT System

Subcutaneous ILRs have been clinically obtainable since 1998 (Medtronic Reveal; Medtronic, Minneapolis, MN), and ILR use for detecting coronary heart rhythm abnormalities in sufferers with syncope, palpitations, AF, and different circumstances through which arrhythmia is suspected has been effectively described within the literature. These small loop recorders are positioned within the subcutaneous house and are leadless. ILRs constantly document the guts rhythm, and when programmed alert standards are met for analysis of arrhythmia, the occasion is captured and saved till retrieved in individual or by way of distant residence monitoring. Most sufferers within the MiD research had a Medtronic Reveal XT ILR implanted, however lately enrolled sufferers obtained an up to date machine, the Medtronic Reveal LINQ (). These screens are implanted subcutaneously with a easy outpatient process utilizing native anesthesia. In sufferers with out ESRD, device-related issues related to ILR implantation embody an infection (1.2%), machine migration, and ache on the implant web site (<1%) (65). Battery life is roughly 3 years, and each gadgets are conditionally permitted for magnetic resonance imaging (1.5 and three.0 T) with out reprogramming, though ready for six weeks after insertion with the XT machine is advisable (65,66). Medicare reimbursement for an ILR is mostly within the vary of $6000–$7000, which incorporates the machine and insertion-related prices.

An external file that holds a picture, illustration, etc.
Object name is CJN.09350915f5.jpg

Reveal and MyCareLink programs. (A) Reveal (backside) and Reveal (prime) implantable screens. (B) MyCareLink monitor. The pictured machine is used with the LINQ system and transmits saved info wirelessly from the implanted monitor to central servers when it’s situated inside roughly ≤30 toes of the implanted monitor. MyCareLink programs used with the Reveal XT machine required that the transmitter be linked to a landline and held as much as the chest wall. (C) Data move from implantable cardiac monitor to web-hosted doctor interface.

Each Reveal XT and Reveal LINQ can detect and document AF in addition to residence monitoring capabilities, however the LINQ machine is 87% smaller (a couple of one third the dimensions of a triple-A battery), affords extra reminiscence (20% extra), and supplies automated nightly downloads of detected arrhythmias. Whereas Reveal XT required holding a landline-connected transmitter over the chest wall, automated nightly downloads from the LINQ monitor to a bedside cellphone–primarily based monitor (MyCareLink monitor [Medtronic, Minneapolis, MN]), enable every day evaluation of affected person’s coronary heart rhythms (). This functionality permits physicians to observe sufferers every day as an alternative of receiving the info solely when the affected person has signs or on the time of scheduled interrogation, as was the observe with the XT machine.

ILRs supply the flexibility to watch sufferers for an prolonged interval (as much as 3 years) (65). For sufferers with rare signs or who require long-term rhythm analysis, these screens present extra info than shorter-term Holter monitoring, wearable patch know-how, exterior loop recorders, or intermittent monitoring gadgets (67). Affected person compliance may be challenge with exterior screens, which limits their effectiveness (68).

MiD Protocol

Overview

The first goal of the MiD research (NCT01779856) was to estimate the proportion of HD sufferers experiencing clinically vital arrhythmias throughout a 6-month major remark interval utilizing the Reveal ILR system. Secondary targets had been to broadly characterize the prevalence of arrhythmia in HD-dependent ESRD and quantify associations with electrolytes, HD process, and quantity parameters.

Examine Inhabitants

Eligibility standards had been designed to maximise generalizability and affected person security (). All analysis complied with the Declaration of Helsinki and was permitted by relevant institutional evaluate boards.

Desk 1.

Inclusion and exclusion standards

Inclusion Standards Exclusion Standards
Age≥ 21 yr Not appropriate for implantation (e.g., cachexia, extreme dermatologic circumstances)
In-center HD≥3 instances/wk or
eGFR<15 ml/min per 1.73 m2 with anticipated HD initiation inside 2 mo
Anticipated survival <6 mo
Left-sided HD catheter in place anticipated to intrude with implantation
Skill to adjust to protocol Thoracic surgical procedure inside 6 mo
An infection with 14 d
Bacteremia inside 60 d
Hemoglobin <10 g/dl on consecutive measurements inside prior 2 mo
Transplantation anticipated inside 6 mo
Modality switch anticipated inside 6 mo
Current pacemaker or ICD

Examine Procedures

Echocardiography (if not carried out throughout the previous 6 months), 12-lead electrocardiography, medical historical past, and medicines had been obtained at baseline, and ILRs had been implanted inside 14 days. For the primary 6 months after implantation, sufferers transmitted Reveal knowledge instantly earlier than all dialysis classes and after every session related to a research blood draw. Postmortem transmission was inspired however was not particularly required by the protocol. Signs, dialysis prescription, ultrafiltration volumes, and peri- and postdialysis very important indicators had been collected at each dialysis session throughout the first 6 months. Blood was drawn each earlier than and after dialysis: twice weekly for 4 weeks and as soon as weekly thereafter via 6 months ( and ). After 6 months, transmissions occurred no less than weekly however knowledge assortment was in any other case restricted to opposed occasions.

Desk 2.

Weekly Session First Session Predialysis First Session Postdialysis Second or Third Session Predialysis Second or Third Session Postdialysis
Wk 1 A+B+LTS D+Ea C D
Wk 2 C D C D
Wk 3 C D C D
Wk 4 C D C D
Wk 5–26 Bb or C D

Desk 3.

A B C D E (Electivea)
Mind natriuretic peptide Albumin Albumin Albumin Albumin
CK/CK-MB Bicarbonate Bicarbonate Bicarbonate Bicarbonate
Hemoglobin A1c BUN BUN BUN Calcium
Excessive-sensitivity C-reactive protein Calcium Calcium Calcium Creatinine
Parathyroid hormone Creatinine Creatinine Creatinine Magnesium
Troponin-T Hematocrit Magnesium Magnesium Phosphorous
Hemoglobin Phosphorous Phosphorous Potassium
Iron Potassium Potassium Sodium
Magnesium Sodium Sodium
Phosphorous
Potassium
Sodium

Examine coordinators reviewed transmissions after the dialysis session to determine prespecified, doubtlessly harmful arrhythmias, which mandated investigator evaluate: VT ≥180 BPM for >15 seconds, asystole >5 seconds, waking (6 a.m.–10 p.m.) coronary heart charge ≤40 BPM for ≥6 seconds, AF for >24 hours or for >12 hours over consecutive days, or symptomatic arrhythmia.

Throughout months 0–6, the research sponsor reviewed patient-marked occasions and transmissions with potential arrhythmias. A core laboratory adjudicated these probably according to the first endpoint. Lengthy-term follow-up continued for a most of 12 months. The research concluded when the final research participant had accomplished 6 months of follow-up. ILR removing at research termination was non-obligatory.

Endpoints

The first research goal was to estimate the proportion of HD sufferers experiencing clinically vital cardiac arrhythmias (CSAs) over 6 months. CSAs are arrhythmias thought-about almost definitely to be related to syncope and cardiac arrest or to trigger signs of hypoperfusion. They had been primarily based on commonplace definitions (69–71), suggestions of an advisory panel, and the detection capabilities of the Reveal machine and included the next:

  • VT≥115 BPM lasting ≥30 seconds (the speed restrict was subsequently modified to ≥130 BPM with a protocol modification).

  • Bradycardia with coronary heart charge ≤40 BPM for ≥6 seconds.

  • Asystole for ≥3 seconds.

  • Affected person-marked (symptomatic) occasions the place electrocardiographic evaluate confirmed an arrhythmia thought-about clinically related within the judgment of the location heart specialist.

Secondary goals had been designed to evaluate machine security, characterize cardiac rhythm and associations with dialysis or scientific occasions, and assess the flexibility of the Reveal machine to detect short-term modifications in electrocardiographic morphology and their affiliation with remedy parameters.

The next secondary goals had been specified: (1) quantifying machine and procedure-related opposed occasions; (2) recording health-related occasions, particularly dying, cardiovascular occasions, and well being care utilization; (3) analyzing the affiliation of arrhythmic occasions with health-related occasions and HD remedy parameters (this goal included CSA, different arrhythmias [e.g., AF], and parameters corresponding to coronary heart charge variability and coronary heart charge pattern); (4) quantifying atrial arrhythmia burden and analyzing associations with HD remedy parameters; and (5) assessing affiliation of captured electrocardiographic morphology and pre- and postdialysis serum electrolyte ranges.

Statistical Analyses

The deliberate pattern measurement was 125 implanted sufferers. With 10% attrition this could have enabled estimation of the proportion of sufferers experiencing CSAs with a 95% confidence interval (95% CI) half-width of lower than 0.1 for any proportion. Preliminary knowledge from the primary 50 enrolled sufferers revealed CSA charges of ≥70%, which allowed estimation of 95% CI half-widths ≤0.15 with out extra enrollment. Thus, recruitment of the complete pattern measurement was not essential to reliably estimate CSA occasion charges or to find out whether or not there was a clinically related incidence of CSA within the HD inhabitants. Given the monetary and logistic challenges of recruitment and restricted potential for qualitative impact from extra enrollment, the research was capped at 66 implanted sufferers. This closing pattern measurement of 66 permits the estimation of the proportion of sufferers experiencing CSA with a 95% CI half-width of <0.13 for any proportion.

The first CSA proportion can be calculated from the cohort finishing 6-month follow-up with 95% CI bounds estimated by the Clopper–Pearson “actual” methodology utilizing the MiD-p modification (72). The evaluation can be repeated in two populations: (1) sufferers with full follow-up, plus these with incomplete knowledge who skilled CSAs, and (2) all implanted sufferers, assuming that these with incomplete follow-up and no CSAs whereas beneath remark had no occasions throughout unobserved follow-up. This can be supplemented with Kaplan–Meier survivor plots of CSA-free survival. A unfavorable binomial mannequin, acceptable for recurrent occasions and permitting for variable follow-up (73), can be used to estimate imply and 95% CI of CSA per patient-year.

Particular Concerns

Use of an invasive monitoring machine in a scientific research is an uncommon characteristic of MiD and raises distinctive points by exposing sufferers to threat in an in any other case observational research. The moral points are usually not distinctive to this design. Radiographic endpoints are regularly utilized in research, for instance, and in addition require radiation publicity with out clear profit; section 1 drug research or “first-in-human” machine research additionally expose folks to threat with out clear profit.

Given the necessity to perceive SCD and arrhythmia trigger within the dialysis inhabitants, the minimally invasive nature of ILR gadgets, and the low charge of infections when utilized in different populations, the usage of Reveal XT and LINQ in MiD was felt to be ethically acceptable. Generally, we advocate assessing “interventional-observational” analysis designs, with an moral framework that balances the significance of the data gained in opposition to potential dangers. Excessive-risk, non–minimally invasive gadgets would not often be acceptable with no potential for particular person profit. Conversely, as gadgets turn out to be smaller and fewer invasive, they might allow observational research of nonserious circumstances. Use of noninvasive instruments ought to usually be thought-about as a substitute, and investigators are obligated to fastidiously evaluate particular person threat earlier than enrolling sufferers in an observational research requiring use of an implantable monitor.

A very thorny challenge is that monitoring knowledge can alter noticed outcomes and bias estimated occasion charges. Detected arrhythmias in MiD, for instance, might mandate modifications in scientific care (e.g., pacemaker implantation, change in dialysis prescription) that modify the chance of subsequent arrhythmia, thereby lowering CSAs and leading to underestimation of the true inhabitants CSA charge.

Full disclosure to contributors and clinicians maximizes potential advantages to contributors but in addition maximizes bias. Sequestering the monitoring knowledge eliminates consequence contamination, however nondisclosure of probably dangerous and treatable circumstances found throughout analysis is ethically unacceptable.

With end-of-study batch evaluation of uncooked monitoring knowledge, outcomes and interpretation of the monitoring knowledge don’t turn out to be obtainable till after the research has concluded. That is just like storing blood samples for batch evaluation on the finish of a research. As a result of the samples (on this case monitoring info) are usually not analyzed or interpreted till after the research, this strategy eliminates the moral issues inherent to withholding analyzed knowledge; nevertheless, it imposes substantial knowledge storage necessities and will inhibit the flexibility to optimally perceive scientific options of occasions or to find out the perfect scientific response. Batch evaluation at common intervals affords a helpful intermediate strategy. Lastly, it could be potential to pick out endpoints, monitoring time frames, or knowledge disclosures so as to restrict biasing of necessary endpoints whereas permitting scientific use of analysis knowledge. In MiD, arrhythmias felt to be harmful, corresponding to asystole and sustained VT, had been reviewed in an ongoing method and shared with research sufferers and their clinicians. Conversely, disclosure of arrhythmias of unsure significance, corresponding to nonsustained VT, was not required.

Baseline Traits of the Examine Inhabitants

Sufferers had been enrolled in India (23 of 66) and the USA (43 of 66). A number of traits of the research inhabitants differed from these of the USA dialysis inhabitants (1). Imply age was decrease; solely 12.1% of sufferers had been ≥70 years of age. The next proportion of sufferers had been black (53.0%), Asian (34.8%), and male (69.7%). Diabetes was current in 63.6% of sufferers, whereas practically half of the sufferers (48.5%) had a historical past of ischemic coronary heart illness. A minority of sufferers had a historical past of arrhythmia (31.8%), and 10.6% had a historical past of AF (). Use of cardiovascular medicines was frequent, with 55%, 33%, and 48% of sufferers utilizing β-blockers, angiotensin-converting enzyme inhibitors, or angiotensin-receptor blockers or statins, respectively. Laboratory parameters () recommended enough supply of dialysis with a imply single pool Kt/V of 1.5±0.4. Potassium (5.0±1.0 mEq/L), hemoglobin (10.6 ±1.2 g/dl), and phosphorous (5.5±2.0 mg/dl) had been every mildly elevated however throughout the anticipated vary for sufferers present process long-term dialysis.

Desk 4.

Baseline traits of enrolled sufferers

Traits All Sufferers (n=66) Sufferers in United States (n=43) Sufferers in India (n=23) P Worth
Imply age at implant±SD, yr (n/N) 56.3±12.2 (66/66) 55.8±11.6 (43/43) 57.2±13.5 (23/23) 0.66
Male intercourse 69.7 (46/66) 62.8 (27/43) 82.6 (19/23) 0.16
Race <0.001
 Asian 34.8 (23/66) 0.0 (0/43) 100.0 (23/23)
 Black 53.0 (35/66) 81.4 (35/43) 0.0 (0/23)
 Different 1.5 (1/66) 2.3 (1/43) 0.0 (0/23)
 White 10.6 (7/66) 16.3 (7/43) 0.0 (0/23)
Hispanic ethnicity 0.0 (0/66) 0.0 (0/43) 0.0 (0/23)
Reason for ESRD
 Diabetes 42.4 (28/66) 34.9 (15/43) 56.5 (13/23) 0.01
 GN 7.6 (5/66) 7.0 (3/43) 8.7 (2/23)
 Hypertension 37.9 (25/66) 51.2 (22/43) 13.0 (3/23)
 Different 12.1 (8/66) 7.0 (3/43) 21.7 (5/23)
Median ESRD classic (IQR), yr (n/N) 2.4 (1.2–5.3) (65/66) 3.5 (1.2–5.7) (42/43) 2.2 (1.1–3.0) (23/23) <0.001
Prior kidney transplant 13.6 (9/66) 11.6 (5/43) 17.4 (4/23) 0.71
Earlier peritoneal dialysis 10.6 (7/66) 14.0 (6/43) 4.3 (1/23) 0.41
Present vascular entry
 AV fistula 70.8 (46/65) 59.5 (25/42) 91.3 (21/23) 0.01
 AV graft 24.6 (16/65) 35.7 (15/42) 4.3 (1/23)
 Catheter 4.6 (3/65) 4.8 (2/42) 4.3 (1/23)
Diabetes 0.61
 None 36.4 (24/66) 37.2 (16/43) 34.8 (8/23)
 Sort 1 4.5 (3/66) 7.0 (3/43) 0.0 (0/23)
 Sort 2 59.1 (39/66) 55.8 (24/43) 65.2 (15/23)
Imply diabetes period±SD, yr (n/N) 17.9±12.8 (37/66) 21.0±13.6 (24/43) 12.1±9.0 (13/23) 0.04
Hyperlipidemia 60.6 (40/66) 74.4 (32/43) 34.8 (8/23) 0.003
Hypertension 84.8 (56/66) 97.7 (42/43) 60.9 (14/23) <0.001
Ischemic coronary heart illness 48.5 (32/66) 51.2 (22/43) 43.5 (10/23) 0.61
Congestive coronary heart failure 25.8 (17/66) 39.5 (17/43) 0.0 (0/23) <0.001
Coronary artery bypass surgical procedure 13.6 (9/66) 11.6 (5/43) 17.4 (4/23) 0.71
Historical past of arrhythmia 31.8 (21/66) 48.8 (21/43) 0.0 (0/23) <0.001
Atrial fibrillation 10.6 (7/66) 16.3 (7/43) 0.0 (0/23) 0.09
Smoking 0.02
 Present 7.6 (5/66) 11.6 (5/43) 0.0 (0/23)
 By no means 69.7 (46/66) 58.1 (25/43) 91.3 (21/23)
 Previous 22.7 (15/66) 30.2 (13/43) 8.7 (2/23)
Imply weight±SD, kg (n/N) 86.7±28.8 (66/66) 97.6±28.7 (43/43) 66.5±14.9 (23/23) <0.001
Physique mass index ≥40 kg/m2 9.1 (6/66) 14.0 (6/43) 0.0 (0/23) 0.08
Imply systolic BP±SD, mmHg (n/N) 140.8±23.4 (66/66) 139.6±25.8 (43/43) 143.0±18.2 (23/23) 0.57
Imply diastolic BP±SD, mmHg (n/N) 76.8±12.9 (66/66) 75.5±15.1 (43/43) 79.1±6.7 (23/23) 0.18
Drugs
 Nonaspirin anticoagulants or anti platelet brokers 15 (10/66) 16 (7/43) 13 (3/23) 1.00
 β-Blockers 55 (36/66) 58 (25/43) 48 (11/23) 0.45
 Calcium channel blockers 59 (39/66) 51 (22/43) 74 (17/23) 0.11
 ACEI or ARB 33 (22/66) 47 (20/43) 9 (2/23) 0.002
 Statin 48 (32/66) 47 (20/43) 52 (12/23) 0.80
 Aspirin 45 (30/66) 49 (21/43) 39 (9/23) 0.60

Desk 5.

Baseline laboratory knowledge of research contributors

Laboratory Worth All Sufferers (n) Sufferers in United States (n) Sufferers in India (n) P Worth
BUN, (mg/dL) 59.7±17.8 (59) 58.6±15.8 (40) 62.2±21.8 (19) 0.47
Creatinine, mg/dl 10.0±3.4 (59) 10.9±3.5 (40) 8.3±2.4 (19) 0.01
Sodium, mEq/L 137.0±4.5 (59) 138.4±3.9 (40) 134.1±4.4 (19) <0.001
Potassium, mEq/L 5.0±1.0 (58) 4.8±0.7 (40) 5.4±1.3 (18) 0.07
Calcium, mg/dl 8.7±0.8 (59) 8.8±0.8 (40) 8.4±0.8 (19) 0.08
Bicarbonate, mEq/L 22.2±3.7 (59) 23.8±2.9 (40) 18.8±2.9 (19) <0.001
Magnesium, mg/dl 2.4±0.5 (59) 2.2±0.3 (40) 2.8±0.6 (19) 0.001
Phosphorous, mg/dl 5.5±2.0 (59) 5.7±2.1 (40) 5.0±1.9 (19) 0.19
Hemoglobin, g/dla 10.6±1.2 (56) 10.8±1.0 (38) 10.2±1.5 (18) 0.12
Serum albumin, g/dl 3.94±0.33 (57) 4.03±0.26 (40) 3.75±0.39 (19) 0.01
Parathyroid hormone, pg/ml 473.7±371.9 473.7±371.9 NA NA
spKT/V 1.5±0.4 (59) 1.5±0.3 (40) 1.4±0.6 (19) 0.44

A number of traits differed considerably between United States and Indian sufferers. Particularly, Indian sufferers weighed much less (66.5 versus 97.6 kg), had been extra more likely to have diabetic kidney illness (56.5% versus 34.9%), had been extra more likely to dialyze by way of an arteriovenous fistula (91.3% versus 59.5%), had a shorter dialysis classic (2.2 versus 3.5 years), and had been much less more likely to have hypertension (60.9% versus 97.7%) than contributors in the USA. Laboratory traits had been usually related, however bicarbonate (18.8 versus 23.8 mEq/L) and sodium (134.1 versus 138.4 mEq/L) concentrations had been decrease in India.

This regional variation and elevated variability in laboratory and scientific traits current challenges and alternatives. Evaluation of country-specific arrhythmia charges is necessary, however the wide selection of traits, corresponding to physique mass index, hypertension, and bicarbonate concentrations, might present a larger potential to research associations of those elements with arrhythmia than would have been potential had the research recruited solely inside the USA. World enrollment ought to thus restrict the impact of country-specific dialysis practices on our findings and will improve relevance to the worldwide HD inhabitants whereas requiring extra cautious extrapolation to the USA inhabitants.

MiD as a Paradigm

The MiD research illustrates the potential of invasive monitoring to enhance understanding of the pathophysiology of ESRD and elucidate the true nature or reason for scientific occasions in dialysis sufferers. From our expertise, it appears clear that when investigators are engaged, dangers are moderately low, analysis questions are necessary, and scientific profit is feasible, dialysis sufferers might be engaged and their collaboration secured in observational research utilizing invasive monitoring procedures.

Future analysis on ILR know-how in ESRD ought to embody research to find out the affiliation between subclinical AF and the chance of stroke, long-term research with adequate pattern measurement to seize terminal cardiac rhythms on the time of SCD, and interventional research testing the impact of individualization of the dialysis prescription on arrhythmia. Gadgets with miniaturized impedance know-how will facilitate learning associations of quantity standing with arrhythmia and extra subtle investigations into hyperlinks between ultrafiltration charge, BP, quantity standing, cardiovascular dying, and intradialytic hypotension. Outdoors of the cardiovascular enviornment, implantable glucose screens stand out as a know-how that might be readily used to definitively decide the true relationship between serum glucose ranges and hemoglobin A1c or scientific outcomes in ESRD (74). Equally, one can envision utilizing stress or move monitoring gadgets to higher perceive entry physiology and trajectories of entry maturation and failure.

Abstract

Understanding the causal sequence of occasions within the pathway to dying is important to figuring out alternatives for prolonging life in ESRD. Regardless of advances in renal care, the interval from the final scientific evaluation till out-of-hospital dying stays ripe for investigation (75–78). In individuals present process in-center HD, common well being care contact limits the time throughout which no very important info is recorded; nevertheless, out-of-center SCD stays frequent, with little details about the hours and days main as much as the ultimate minutes of life. Data on these intervals in home-care sufferers is extra restricted with respect to cardiac rhythm and very important standing (79).

Typical cardiac pacemakers have diminished the mortality related to bradycardia and permit bradycardic sufferers to have regular actuarial survival in contrast with age- and sex-matched cohorts (80). In these with accepted indications for implantable cardioverter-defibrillators (ICDs), the speed of acceptable remedy for deadly rhythms is roughly 20% over the lifetime of the implant (80), and first and secondary prevention of SCD with ICDs in sufferers with left ventricular dysfunction improves survival of those teams. In a subset of sufferers with left ventricular dysfunction who’ve ventricular dyssynchrony (e.g., extended left bundle-branch block morphology QRS advanced on electrocardiography), the addition of a left ventricular lead and biventricular pacing improves survival from each sudden and pump failure dying (82).

Nonetheless, the precise translation of those therapies to sufferers with superior CKD and ESRD is proscribed, as famous above, by an absence of information that enable inferences on their potential dangers and advantages. ICDs, for instance, face increased defibrillation thresholds which will inhibit profitable cardioversion of VT/fibrillation in sufferers with ESRD (83). This may occasionally replicate larger levels of total left ventricular fibrosis and hypertrophy in contrast with these with out years of CKD. There may be additionally restricted details about the necessity for backup bradycardia pacing in sufferers with ESRD who’ve ICDs implanted but might have a scientific occasion the place bradycardia is the complicating rhythm. Lastly, and most critically, the proportion of dying that’s really avoidable with machine remedy versus how a lot is actually attributable to pump failure or noncardiac major causes that can not be influenced by any type of machine remedy stays unknown.

The MiD research is uniquely designed to realize important insights into sufferers each within the clinic and hospital and, extra necessary, locally and households through which they stay. Recording the newest baseline rhythm, important triggers (untimely depolarizations, pauses), pathologic intermediate rhythms (monomorphic, polymorphic VT), and terminal patterns (coronary heart block, VT, VF, systole, and different types of pulseless electrical exercise) will present essential knowledge permitting investigators to start piecing collectively the sequence of occasions and proximate causes of the final minutes of life in ESRD. Equally, identification of scientific, demographic, or electrophysiologic variables related to the ultimate electrical sequence might show helpful for predicting deadly, but treatable, rhythms, for the potential utility of and figuring out these almost definitely to profit from ICD insertion, for figuring out whether or not back-up pacing capabilities are wanted, or for figuring out whether or not sufferers would profit from withdrawal of nodal blockade (e.g., β-blockers).

By capturing the complete constellation of cardiac rhythm throughout a protracted interval, the MiD research will present info on the extent to which beforehand undetected AF or different tachyarrhythmias and bradyarrhythmias contribute to morbidity in ESRD. Lastly, as famous beforehand, the detailed seize of scientific knowledge in MiD is important for correlating captured rhythms with concurrent scientific signs to keep away from complicated “agonal” rhythms that seem secondary to another life-ending occasion, corresponding to sepsis or stroke (for which software of cardiac pacing gadgets will not be acceptable), with major arrhythmia as a reason for dying.

Evaluation of blood chemistries and knowledge on the dialysis prescription from MiD might alternatively determine prescription traits or electrolyte ranges strongly related to the prevalence of arrhythmia. Thus, the ultimate outcomes might counsel methods to tailor the dialysis prescription so as to restrict arrhythmia. On this regard, associations between blood-dialysate potassium or calcium gradients and arrhythmia prevalence in MiD are eagerly anticipated.

Sooner or later, notably as point-of-care info turns into obtainable, long-term monitoring might enable nephrologists to change the dialysis prescription in response to minute-by-minute modifications in electrocardiographic morphology or the peridialytic prevalence of arrhythmia. Lengthy-term monitoring would possibly enable the identification of sufferers with subclinical AF more likely to profit from anticoagulation. ILR research may facilitate dedication of whether or not sure dialysate-serum electrolyte gradients are related to a better probability of arrhythmia and must be prevented. Lastly, scientific trials evaluating outcomes following randomization to an ILR with detection of and response to arrhythmia versus routine commonplace of care could also be thought-about to find out whether or not the potential of those gadgets can cut back mortality within the dialysis inhabitants.

In abstract, we imagine that leveraging trendy cardiac rhythm monitoring in individuals with ESRD supplies an necessary alternative to advance the science of cardiorenal medication. We await the outcomes contributed by devoted and altruistic sufferers, households, and investigators who’re finishing up the protocol on the time of this writing.

Disclosures

All the authors obtained analysis assist and/or consulting charges from Medtronic (Minneapolis, MN) in relationship to the design of the research. D.M.C. obtained consulting from Questcor Prescribed drugs (Anaheim, CA), professional witness charges associated to dialysate composition from Fresenius Medical Care (Waltham, MA), and charges associated to service on scientific occasions committee from PLC Medical Programs (Milford, MA). J.D.R. obtained audio system bureau, marketing consultant, and analysis assist from Medtronic; audio system bureau and analysis assist from St Jude Medical (St. Paul, MN); and audio system bureau from Biotronik (Berlin, Germany). C.A.H. obtained analysis assist from Zoll (Chelmsford, MA) and inventory/fairness curiosity from Cambridge Coronary heart, Boston Scientific (Tewksbury, MA).

Acknowledgments

The authors want to acknowledge the assist and suggestions from the research group at Medtronic together with John Burnes and Amy Roettger.

The MiD research was funded by Medtronic and designed by Medtronic in collaboration with an advisory committee that included the authors.

The MiD investigators and committees are listed within the Supplemental Materials.

References

1. U.S. Renal Information System: USRDS 2013 Annual Information Report: Atlas of Finish-Stage Renal Illness in the USA, Bethesda, MD, Nationwide Institutes of Well being, Nationwide Institute of Diabetes and Digestive and Kidney Illnesses, 2013 [Google Scholar]
2. Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E; German Diabetes and Dialysis Examine Investigators: Atorvastatin in sufferers with sort 2 diabetes mellitus present process hemodialysis. N Engl J Med
353: 238–248, 2005 [PubMed] [Google Scholar]
3. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D, Levey AS; HEMO Examine Group: Cardiac ailments in upkeep hemodialysis sufferers: Outcomes of the HEMO Examine. Kidney Int
65: 2380–2389, 2004 [PubMed] [Google Scholar]
4. Wheeler DC, London GM, Parfrey PS, Block GA, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Kubo Y, Mahaffey KW, Goodman WG, Moe SM, Trotman ML, Abdalla S, Chertow GM, Herzog CA; EValuation Of Cinacalcet HCl Remedy to Decrease CardioVascular Occasions (EVOLVE) Trial Investigators: Results of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular occasions in sufferers receiving hemodialysis: The EValuation Of Cinacalcet HCl Remedy to Decrease CardioVascular Occasions (EVOLVE) trial. J Am Coronary heart Assoc
3: e001363, 2014 [PMC free article] [PubMed] [Google Scholar]
5. Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH, Ritz E: Heart problems in continual kidney illness. A scientific replace from Kidney Illness: Enhancing World Outcomes (KDIGO). Kidney Int
80: 572–586, 2011 [PubMed] [Google Scholar]
6. Weinhandl E, Constantini E, Everson S, Gilbertson D, Li S, Strong C, Anger M, Bhat JG, DeOreo P, Krishnan M, Nissenson A, Johnson D, Ikizler TA, Maddux F, Sadler J, Tyshler L, Parker T, third, Schiller B, Smith B, Lindenfeld S, Collins AJ: Peer kidney care initiative 2014 report: dialysis care and outcomes in the USA. Am J Kidney Dis
65: S1–S140, 2015 [PubMed] [Google Scholar]
7. Drechsler C, Grootendorst DC, Pilz S, Tomaschitz A, Krane V, Dekker F, März W, Ritz E, Wanner C: Losing and sudden cardiac dying in hemodialysis sufferers: A submit hoc evaluation of 4D (Die Deutsche Diabetes Dialyse Studie). Am J Kidney Dis
58: 599–607, 2011 [PubMed] [Google Scholar]
8. Parekh RS, Plantinga LC, Kao WH, Meoni LA, Jaar BG, Fink NE, Powe NR, Coresh J, Klag MJ: The affiliation of sudden cardiac dying with irritation and different conventional threat elements. Kidney Int
74: 1335–1342, 2008 [PubMed] [Google Scholar]
9. Chan KE, Newton-Cheh C, Gusella JF, Maddux FW: Heritability of threat for sudden cardiac arrest in ESRD. J Am Soc Nephrol
26: 2815–2820, 2015 [PMC free article] [PubMed] [Google Scholar]
11. Solar Q, Music Okay, Shen X, Cai Y: The affiliation between KCNQ1 gene polymorphism and sort 2 diabetes threat: A meta-analysis. PLoS One
7: e48578, 2012 [PMC free article] [PubMed] [Google Scholar]
12. Multicentre, cross-sectional research of ventricular arrhythmias in chronically haemodialysed sufferers. Gruppo Emodialisi e Patologie Cardiovasculari. Lancet
2: 305–309, 1988 [PubMed] [Google Scholar]
13. Sforzini S, Latini R, Mingardi G, Vincenti A, Redaelli B: Ventricular arrhythmias and four-year mortality in haemodialysis sufferers. Gruppo Emodialisi e Patologie Cardiovascolari. Lancet
339: 212–213, 1992 [PubMed] [Google Scholar]
14. Wan C, Herzog CA, Zareba W, Szymkiewicz SJ: Sudden cardiac arrest in hemodialysis sufferers with wearable cardioverter defibrillator. Ann Noninvasive Electrocardiol
19: 247–257, 2014 [PMC free article] [PubMed] [Google Scholar]
15. Wong MC, Kalman JM, Pedagogos E, Toussaint N, Vohra JK, Sparks PB, Sanders P, Kistler PM, Halloran Okay, Lee G, Joseph SA, Morton JB: Bradycardia and asystole is the predominant mechanism of sudden cardiac dying in sufferers with continual kidney illness. J Am Coll Cardiol
65: 1263–1265, 2015 [PubMed] [Google Scholar]
16. Wong MC, Kalman JM, Pedagogos E, Toussaint N, Vohra JK, Sparks PB, Sanders P, Kistler PM, Halloran Okay, Lee G, Joseph SA, Morton JB: Temporal distribution of arrhythmic occasions in continual kidney illness: Highest incidence within the lengthy interdialytic interval. Coronary heart Rhythm
12: 2047–2055, 2015 [PubMed] [Google Scholar]
17. Karnik JA, Younger BS, Lew NL, Herget M, Dubinsky C, Lazarus JM, Chertow GM: Cardiac arrest and sudden dying in dialysis models. Kidney Int
60: 350–357, 2001 [PubMed] [Google Scholar]
18. Pun PH, Lehrich RW, Honeycutt EF, Herzog CA, Middleton JP: Modifiable threat elements related to sudden cardiac arrest inside hemodialysis clinics. Kidney Int
79: 218–227, 2011 [PubMed] [Google Scholar]
19. Pun PH, Horton JR, Middleton JP: Dialysate calcium focus and the chance of sudden cardiac arrest in hemodialysis sufferers. Clin J Am Soc Nephrol
8: 797–803, 2013 [PMC free article] [PubMed] [Google Scholar]
20. Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y: Hypomagnesemia is a major predictor of cardiovascular and non-cardiovascular mortality in sufferers present process hemodialysis. Kidney Int
85: 174–181, 2014 [PubMed] [Google Scholar]
21. Foley RN, Gilbertson DT, Murray T, Collins AJ: Lengthy interdialytic interval and mortality amongst sufferers receiving hemodialysis. N Engl J Med
365: 1099–1107, 2011 [PubMed] [Google Scholar]
22. Bleyer AJ, Russell GB, Satko SG: Sudden and cardiac dying charges in hemodialysis sufferers. Kidney Int
55: 1553–1559, 1999 [PubMed] [Google Scholar]
23. Fotheringham J, Fogarty DG, El Nahas M, Campbell MJ, Farrington Okay: The mortality and hospitalization charges related to the lengthy interdialytic hole in thrice-weekly hemodialysis sufferers. Kidney Int
88: 569–575, 2015 [PubMed] [Google Scholar]
24. Zhang H, Schaubel DE, Kalbfleisch JD, Bragg-Gresham JL, Robinson BM, Pisoni RL, Canaud B, Jadoul M, Akiba T, Saito A, Port FK, Saran R: Dialysis outcomes and evaluation of observe patterns suggests the dialysis schedule impacts day-of-week mortality. Kidney Int
81: 1108–1115, 2012 [PMC free article] [PubMed] [Google Scholar]
25. Wolk R: Arrhythmogenic mechanisms in left ventricular hypertrophy. Europace
2: 216–223, 2000 [PubMed] [Google Scholar]
26. Huikuri HV, Castellanos A, Myerburg RJ: Sudden dying as a consequence of cardiac arrhythmias. N Engl J Med
345: 1473–1482, 2001 [PubMed] [Google Scholar]
27. Herzog CA, Mangrum JM, Passman R: Sudden cardiac dying and dialysis sufferers. Semin Dial
21: 300–307, 2008 [PubMed] [Google Scholar]
28. Spaulding CM, Joly LM, Rosenberg A, Monchi M, Weber SN, Dhainaut JF, Carli P: Instant coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med
336: 1629–1633, 1997 [PubMed] [Google Scholar]
29. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS: Plasma norepinephrine predicts survival and incident cardiovascular occasions in sufferers with end-stage renal illness. Circulation
105: 1354–1359, 2002 [PubMed] [Google Scholar]
30. Stenvinkel P: Irritation in end-stage renal illness: the hidden enemy. Nephrology (Carlton)
11: 36–41, 2006 [PubMed] [Google Scholar]
31. Foley RN, Curtis BM, Randell EW, Parfrey PS: Left ventricular hypertrophy in new hemodialysis sufferers with out symptomatic cardiac illness. Clin J Am Soc Nephrol
5: 805–813, 2010 [PMC free article] [PubMed] [Google Scholar]
32. Mall G, Huther W, Schneider J, Lundin P, Ritz E: Diffuse intermyocardiocytic fibrosis in uraemic sufferers. Nephrol Dial Transplant
5: 39–44, 1990 [PubMed] [Google Scholar]
33. Amann Okay, Breitbach M, Ritz E, Mall G: Myocyte/capillary mismatch within the coronary heart of uremic sufferers. J Am Soc Nephrol
9: 1018–1022, 1998 [PubMed] [Google Scholar]
34. McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker CS, Camici PG: Hemodialysis-induced cardiac dysfunction is related to an acute discount in international and segmental myocardial blood move. Clin J Am Soc Nephrol
3: 19–26, 2008 [PMC free article] [PubMed] [Google Scholar]
35. Charytan DM, Padera R, Helfand AM, Zeisberg M, Xu X, Liu X, Himmelfarb J, Cinelli A, Kalluri R, Zeisberg EM: Elevated focus of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in sufferers with continual kidney illness. Int J Cardiol
176: 99–109, 2014 [PMC free article] [PubMed] [Google Scholar]
36. Matsumoto Y, Ueda S, Yamagishi S, Matsuguma Okay, Shibata R, Fukami Okay, Matsuoka H, Imaizumi T, Okuda S: Dimethylarginine dimethylaminohydrolase prevents development of renal dysfunction by inhibiting lack of peritubular capillaries and tubulointerstitial fibrosis in a rat mannequin of continual kidney illness. J Am Soc Nephrol
18: 1525–1533, 2007 [PubMed] [Google Scholar]
37. Repo JM, Rantala IS, Honkanen TT, Mustonen JT, Kööbi P, Tahvanainen AM, Niemelä OJ, Tikkanen I, Rysä JM, Ruskoaho HJ, Pörsti IH: Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol. Kidney Int
72: 977–984, 2007 [PubMed] [Google Scholar]
38. Paulis L, Matuskova J, Adamcova M, Pelouch V, Simko J, Krajcirovicova Okay, Potacova A, Hulin I, Janega P, Pechanova O, Simko F: Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: Impact of L-arginine and spironolactone. Acta Physiol (Oxf)
194: 45–55, 2008 [PubMed] [Google Scholar]
39. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann Okay, Model M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M: FGF23 induces left ventricular hypertrophy. J Clin Make investments
121: 4393–4408, 2011 [PMC free article] [PubMed] [Google Scholar]
40. Brilla CG: Renin-angiotensin system mediated mechanisms: Cardioreparation and cardioprotection. Coronary heart
84 Suppl 1: i18–19:dialogue i50, 2000 [PMC free article] [PubMed] [Google Scholar]
41. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, Kahaleh MB, Xie Z, Malhotra D, Kolodkin NI, Lakatta EG, Fedorova OV, Bagrov AY, Shapiro JI: Central function for the cardiotonic steroid marinobufagenin within the pathogenesis of experimental uremic cardiomyopathy. Hypertension
47: 488–495, 2006 [PubMed] [Google Scholar]
42. Mizobuchi M, Nakamura H, Tokumoto M, Finch J, Morrissey J, Liapis H, Slatopolsky E: Myocardial results of VDR activators in renal failure. J Steroid Biochem Mol Biol
121: 188–192, 2010 [PMC free article] [PubMed] [Google Scholar]
43. Saffitz JE: The pathology of sudden cardiac dying in sufferers with ischemic coronary heart disease–arrhythmology for anatomic pathologists. Cardiovasc Pathol
14: 195–203, 2005 [PubMed] [Google Scholar]
44. Goldstein BA, Arce CM, Hlatky MA, Turakhia M, Setoguchi S, Winkelmayer WC: Developments within the incidence of atrial fibrillation in older sufferers initiating dialysis in the USA. Circulation
126: 2293–2301, 2012 [PMC free article] [PubMed] [Google Scholar]
45. Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S: The rising prevalence of atrial fibrillation amongst hemodialysis sufferers. J Am Soc Nephrol
22: 349–357, 2011 [PMC free article] [PubMed] [Google Scholar]
46. Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM: Systematic evaluate and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in sufferers on dialysis. Nephrol Dial Transplant
27: 3816–3822, 2012 [PubMed] [Google Scholar]
47. Tekce H, Ozturk S, Aktas G, Tekce BK, Erdem A, Ozyasar M, Duman TT, Yazici M: The results of a single dialysis session on atrial electromechanical conduction instances and capabilities. Kidney Blood Press Res
37: 622–630, 2013 [PubMed] [Google Scholar]
48. Steinberg JS, Zelenkofske S, Wong SC, Gelernt M, Sciacca R, Menchavez E: Worth of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgical procedure. Circulation
88: 2618–2622, 1993 [PubMed] [Google Scholar]
49. Fukunami M, Yamada T, Ohmori M, Kumagai Okay, Umemoto Okay, Sakai A, Kondoh N, Minamino T, Hoki N: Detection of sufferers in danger for paroxysmal atrial fibrillation throughout sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation
83: 162–169, 1991 [PubMed] [Google Scholar]
50. Ozben B, Toprak A, Koc M, Sumerkan M, Tanrikulu AM, Papila-Topal N, Kefeli US, Cincin AA, Baykan O, Fak AS: P wave dispersion will increase throughout hemodialysis classes. Nephron Clin Pract
112: c171–c176, 2009 [PubMed] [Google Scholar]
51. Shimada Okay, Tomita T, Kamijo Y, Higuchi M, Ito Okay, Koizumi Y, Yamamoto Okay, Aizawa Okay, Koshikawa M, Kasai H, Izawa A, Miyashita Y, Kumazaki S, Koyama J, Ikeda U: Hemodialysis-induced P-wave signal-averaged electrocardiogram alterations are indicative of vulnerability to atrial arrhythmias. Circ J
76: 612–617, 2012 [PubMed] [Google Scholar]
52. Szabó Z, Kakuk G, Fülöp T, Mátyus J, Balla J, Kárpáti I, Juhász A, Kun C, Karányi Z, Lorincz I: Results of haemodialysis on most P wave period and P wave dispersion. Nephrol Dial Transplant
17: 1634–1638, 2002 [PubMed] [Google Scholar]
53. Jaroszyński AJ, Głowniak A, Sodolski T, Załuska W, Widomska-Czekajska T, Ksiazek A: Impact of haemodialysis on signal-averaged electrocardiogram P-wave parameters. Nephrol Dial Transplant
21: 425–430, 2006 [PubMed] [Google Scholar]
54. Buiten MS, de Bie MK, Rotmans JI, Gabreëls BA, van Dorp W, Wolterbeek R, Trines SA, Schalij MJ, Jukema JW, Rabelink TJ, van Erven L: The dialysis process as a set off for atrial fibrillation: New insights within the improvement of atrial fibrillation in dialysis sufferers. Coronary heart
100: 685–690, 2014 [PubMed] [Google Scholar]
55. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an unbiased threat issue for stroke: the Framingham Examine. Stroke
22: 983–988, 1991 [PubMed] [Google Scholar]
56. Wetmore JB, Ellerbeck EF, Mahnken JD, Phadnis M, Rigler SK, Mukhopadhyay P, Spertus JA, Zhou X, Hou Q, Shireman TI: Atrial fibrillation and threat of stroke in dialysis sufferers. Ann Epidemiol
23: 112–118, 2013 [PMC free article] [PubMed] [Google Scholar]
57. Li SY, Chen YT, Chen TJ, Tsai LW, Yang WC, Chen TW: Mesenteric ischemia in sufferers with end-stage renal illness: A nationwide longitudinal research. Am J Nephrol
35: 491–497, 2012 [PubMed] [Google Scholar]
58. Combe C, Albert JM, Bragg-Gresham JL, Andreucci VE, Disney A, Fukuhara S, Goodkin DA, Gillespie BW, Saito A, Jadoul M, Pisoni RL: The burden of amputation amongst hemodialysis sufferers within the Dialysis Outcomes and Observe Patterns Examine (DOPPS). Am J Kidney Dis
54: 680–692, 2009 [PubMed] [Google Scholar]
59. Zimmermann AJ, Bossard M, Aeschbacher S, Schoen T, Voellmin G, Suter Y, Lehmann A, Hochgruber T, Pumpol Okay, Sticherling C, Kühne M, Conen D, Kaufmann BA: Results of sinus rhythm upkeep on left coronary heart operate after electrical cardioversion of atrial fibrillation: implications for tachycardia-induced cardiomyopathy. Can J Cardiol
31: 36–43, 2015 [PubMed] [Google Scholar]
60. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook dinner J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas GA; MOST Investigators: Atrial excessive charge episodes detected by pacemaker diagnostics predict dying and stroke: report of the Atrial Diagnostics Ancillary Examine of the MOde Choice Trial (MOST). Circulation
107: 1614–1619, 2003 [PubMed] [Google Scholar]
61. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH; ASSERT Investigators: Subclinical atrial fibrillation and the chance of stroke. N Engl J Med
366: 120–129, 2012 [PubMed] [Google Scholar]
62. Karthikeyan G, Ananthakrishnan R, Devasenapathy N, Narang R, Yadav R, Seth S, Singh S, Goswami KC, Bahl VK: Transient, subclinical atrial fibrillation and threat of systemic embolism in sufferers with rheumatic mitral stenosis in sinus rhythm. Am J Cardiol
114: 869–874, 2014 [PubMed] [Google Scholar]
63. Zimetbaum P, Waks JW, Ellis ER, Glotzer TV, Passman RS: Position of atrial fibrillation burden in assessing thromboembolic threat. Circ Arrhythm Electrophysiol
7: 1223–1229, 2014 [PubMed] [Google Scholar]
64. Sanna T, Diener H-C, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg Okay, Brachmann J: Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med
370: 2478–2486, 2014 [PubMed] [Google Scholar]
67. Zimetbaum P, Goldman A: Ambulatory arrhythmia monitoring: Choosing the proper machine. Circulation
122: 1629–1636, 2010 [PubMed] [Google Scholar]
68. Gladstone DJ, Sharma M, Spence JD; EMBRACE Steering Committee and Investigators: Cryptogenic stroke and atrial fibrillation. N Engl J Med
371: 1260, 2014 [PubMed] [Google Scholar]
69. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW; CAST Investigators: Mortality and morbidity in sufferers receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med
324: 781–788, 1991 [PubMed] [Google Scholar]
72. Newcombe RG: Two-sided confidence intervals for the one proportion: Comparability of seven strategies. Stat Med
17: 857–872, 1998 [PubMed] [Google Scholar]
73. Cook dinner RJ, Lawless J: The Stastical Evaluation of Recurrent Occasions, New York, Springer, 2007 [Google Scholar]
74. Williams ME, Lacson E, Jr, Teng M, Ofsthun N, Lazarus JM: Hemodialyzed sort I and sort II diabetic sufferers within the US: Traits, glycemic management, and survival. Kidney Int
70: 1503–1509, 2006 [PubMed] [Google Scholar]
75. Dumler F, McCullough PA: Optimum dialysis for the end-stage renal illness affected person with heart problems. Adv Continual Kidney Dis
11: 261–273, 2004 [PubMed] [Google Scholar]
76. Keeley EC, McCullough PA: Coronary revascularization in sufferers with end-stage renal illness: Dangers, advantages, and optimum methods. Rev Cardiovasc Med
4: 125–130, 2003 [PubMed] [Google Scholar]
77. McCullough PA: Alternatives for enchancment within the cardiovascular care of sufferers with end-stage renal illness. Adv Continual Kidney Dis
11: 294–303, 2004 [PubMed] [Google Scholar]
78. Woo KT, Wong KS, Chan CM: Medical trials of the previous decade within the administration of continual kidney illness. Rev Current Clin Trials
4: 159–162, 2009 [PubMed] [Google Scholar]
79. Culleton BF, Asola MR: The influence of brief every day and nocturnal hemodialysis on high quality of life, cardiovascular threat and survival. J Nephrol
24: 405–415, 2011 [PubMed] [Google Scholar]
80. Kusumoto FM, Phillips R, Goldschlager N: Pacing remedy within the aged. Am J Geriatr Cardiol
11: 305–316, 2002 [PubMed] [Google Scholar]
82. Yousuf O, Chrispin J, Tomaselli GF, Berger RD: Medical administration and prevention of sudden cardiac dying. Circ Res
116: 2020–2040, 2015 [PubMed] [Google Scholar]
83. Wase A, Basit A, Nazir R, Jamal A, Shah S, Khan T, Mohiuddin I, White C, Saklayen M, McCullough PA: Affect of continual kidney illness upon survival amongst implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol
11: 199–204, 2004 [PubMed] [Google Scholar]

Leave a Reply

Your email address will not be published. Required fields are marked *